ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC30163-10mM(1mLinDMSO) |
|
598-02-7 |
Diethyl phosphate (Diethyl phosphoric acid)
|
0 | C4H11O4P | |
GC30162-50mg |
|
1637-39-4 |
trans-Zeatin
|
0 | C10H13N5O | |
GC30162-10mg |
|
1637-39-4 |
trans-Zeatin
|
0 | C10H13N5O | |
GC30162-10mM(1mLinDMSO) |
|
1637-39-4 |
trans-Zeatin
|
0 | C10H13N5O | |
GC30161-5mg |
|
1010386-62-5 |
CY3-YNE
|
0 | C34H42N3O7S2 | |
GC30161-10mM(1mLinDMSO) |
|
1010386-62-5 |
CY3-YNE
|
0 | C34H42N3O7S2 | |
GC30160-5g |
|
9004-32-4 |
Cellulose carboxymethyl ether sodium
|
0 | CH3 | |
GC30159-100mg |
|
294-90-6 |
Cyclen
|
0 | C8H20N4 | |
GC30158-100mg |
|
443913-15-3 |
p38-α MAPK-IN-1
|
0 | C27H35N5O3 | |
GC30158-50mg |
|
443913-15-3 |
p38-α MAPK-IN-1
|
0 | C27H35N5O3 | |
GC30158-10mg |
|
443913-15-3 |
p38-α MAPK-IN-1
|
0 | C27H35N5O3 | |
GC30158-5mg |
|
443913-15-3 |
p38-α MAPK-IN-1
|
0 | C27H35N5O3 | |
GC30158-1mg |
|
443913-15-3 |
p38-α MAPK-IN-1
|
0 | C27H35N5O3 | |
GC30158-10mM(1mLinDMSO) |
|
443913-15-3 |
p38-α MAPK-IN-1
|
0 | C27H35N5O3 | |
GC30157-100mg |
|
246256-50-8 |
5(6)-TAMRA SE (5(6)-Carboxytetramethylrhodamine N-succinimidyl ester)
|
0 | C29H25N3O7 | |
GC30157-50mg |
|
246256-50-8 |
5(6)-TAMRA SE (5(6)-Carboxytetramethylrhodamine N-succinimidyl ester)
|
0 | C29H25N3O7 | |
GC30157-10mg |
|
246256-50-8 |
5(6)-TAMRA SE (5(6)-Carboxytetramethylrhodamine N-succinimidyl ester)
|
0 | C29H25N3O7 | |
GC30157-10mM(1mLinDMSO) |
|
246256-50-8 |
5(6)-TAMRA SE (5(6)-Carboxytetramethylrhodamine N-succinimidyl ester)
|
0 | C29H25N3O7 | |
GC30156-100mg |
|
38136-70-8 |
Brevianamide F (Cyclo(L-Pro-L-Trp))
|
0 | C16H17N3O2 | |
GC30156-50mg |
|
38136-70-8 |
Brevianamide F (Cyclo(L-Pro-L-Trp))
|
0 | C16H17N3O2 | |